Development and Application of Tele-Neuro Rehabilitation System

NCT05031403 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2021-09-01

No results posted yet for this study

Summary

Disability due to neurological diseases is increasing in our country and world. With regular physiotherapy and rehabilitation, as well as patients' symptoms are brought under control, their affected functions in daily life are achieved and levels of independence and physical activity increase. Thus, the patients' quality of life and participation in social life is improved and patients are supported in physical, social and psychological terms. In recent years, it has been reported that exercise with telerehabilitation systems increase the compliance and participation of patients to the treatment, and even this system seems as effective as standard rehabilitation practices. Delivering the treatment through telerehabilitation system when that patients cannot receive it in the hospital due to epidemic, restriction, transfer difficulties, personal and environmental limitations will enable patients to receive the rehabilitation services.Telerehabilitation system is frequently encountered in the abroad, but there are limited systems with Turkish version specific to this patient group in our country. The aim of project is to develop and detect the efficiency of a telerehabilitation system which is used to assess, follow and design home-based rehabilitation program among individuals with chronic neurological diseases who have difficulty in participating in physiotherapy and rehabilitation services because of personal or environmental reasons.

Conditions

Interventions

OTHER

Telerehabilitaton

Patients will be asked to apply the rehabilitation program defined for them 3 days a week for 8 weeks. A training session will last approximately 45-60 minutes.

OTHER

Home Exercise

Patients will be asked to apply the rehabilitation program for themselves with an exercise brochure. This therapy will last 3 days a week for 8 weeks.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER
  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Ela Tarakcı, Prof. · Istanbul University-Cerrahpaşa Faculty of Health Sciences

  • Burcu Ersöz Hüseyinsinoğlu, Assoc. Prof · Istanbul University-Cerrahpaşa Faculty of Health Sciences

  • Murat Kürtüncü, MD · Istanbul University-Capa Faculty of Medicine, Department of Neurology

  • Muhammed Erdem İsenkul, Asst. Prof. · Istanbul University-Cerrahpaşa Faculty of Engineering

  • Pelin Vural · Istanbul University-Cerrahpasa Institute of Postgraduate Education

  • Recep Örmen · Istanbul University-Cerrahpasa Institute of Postgraduate Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-09-01
Completion
2022-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031403 on ClinicalTrials.gov